Naloxone Distribution on the Inpatient Psychiatric Unit: Identifying Gaps Between Current Prescribing Practices and Patient Need.
Saved in:
| Title: | Naloxone Distribution on the Inpatient Psychiatric Unit: Identifying Gaps Between Current Prescribing Practices and Patient Need. |
|---|---|
| Authors: | Stevens, Kathryn (AUTHOR), Urmanche, Adelya (AUTHOR), Lynch, Sean T. (AUTHOR) |
| Source: | Substance Use & Misuse. 2026, Vol. 61 Issue 8, p1304-1310. 7p. |
| Subjects: | Drug overdose, Health services accessibility, Psychiatry, T-test (Statistics), Hospital care, Medical care, Retrospective studies, Descriptive statistics, Chi-squared test, Hospital medical staff, Professions, Physician practice patterns, Attitudes of medical personnel, Medical records, Acquisition of data, Naloxone, Psychiatric hospitals, Drug prescribing, Quality assurance, Data analysis software, Medical needs assessment |
| Geographic Terms: | New York (State) |
| Abstract: | Objective: Opioid overdoses are a major cause of mortality, and naloxone, an effective opioid antagonist, plays a critical role in reversing overdoses. This study aimed to evaluate naloxone prescribing practices by psychiatry residents on inpatient psychiatric units, and to assess residents' attitudes toward prescribing naloxone. Methods: This quality improvement initiative involved a retrospective chart review of patients admitted to a 64-bed standalone psychiatric hospital between December 2023 and March 2024, and who were identified as being at elevated risk for opioid overdose (N = 90, 64 male, 26 female). Demographic information and naloxone kit provision at discharge were reviewed. Following data collection, a resident reeducation session was conducted, with pre- (N = 24) and post- (N = 17) surveys assessing knowledge, attitudes, and barriers to naloxone distribution. Results: Among patients identified with elevated risk for opioid overdose, 37.8% received a naloxone kit prior to discharge. No significant relationships were found between naloxone prescribing and overdose history, urine drug screening result, diagnosis, or any sociodemographic factors. Results from the pre- and post- training surveys administered to the residents demonstrated that although 100% felt responsible for offering kits, approximately one third rarely did so, citing time constraints and workflow confusion. Conclusions: Naloxone is under-prescribed to patients at elevated risk of opioid overdose in inpatient psychiatric settings. To address this, naloxone should be offered to all patients upon discharge. Streamlining workflow procedures and enhancing resident education could facilitate increased naloxone distribution and improve community access, ultimately reducing overdose rates. [ABSTRACT FROM AUTHOR] |
| Copyright of Substance Use & Misuse is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objective: Opioid overdoses are a major cause of mortality, and naloxone, an effective opioid antagonist, plays a critical role in reversing overdoses. This study aimed to evaluate naloxone prescribing practices by psychiatry residents on inpatient psychiatric units, and to assess residents' attitudes toward prescribing naloxone. Methods: This quality improvement initiative involved a retrospective chart review of patients admitted to a 64-bed standalone psychiatric hospital between December 2023 and March 2024, and who were identified as being at elevated risk for opioid overdose (N = 90, 64 male, 26 female). Demographic information and naloxone kit provision at discharge were reviewed. Following data collection, a resident reeducation session was conducted, with pre- (N = 24) and post- (N = 17) surveys assessing knowledge, attitudes, and barriers to naloxone distribution. Results: Among patients identified with elevated risk for opioid overdose, 37.8% received a naloxone kit prior to discharge. No significant relationships were found between naloxone prescribing and overdose history, urine drug screening result, diagnosis, or any sociodemographic factors. Results from the pre- and post- training surveys administered to the residents demonstrated that although 100% felt responsible for offering kits, approximately one third rarely did so, citing time constraints and workflow confusion. Conclusions: Naloxone is under-prescribed to patients at elevated risk of opioid overdose in inpatient psychiatric settings. To address this, naloxone should be offered to all patients upon discharge. Streamlining workflow procedures and enhancing resident education could facilitate increased naloxone distribution and improve community access, ultimately reducing overdose rates. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10826084 |
| DOI: | 10.1080/10826084.2025.2602836 |
